Luna Medical Technologies Inc. Announces New President And Director.
VANCOUVER, B.C.--(BW HEALTHWIRE)--Oct. 17, 2000
Dr. James Swanney accepts the position of President of Luna Medical Technologies Inc. (the "Company") (OTCBB:LNMD)
The Company wishes to announce the appointment of Dr. James Swanney as President of Luna Medical Technologies Inc. Over the past 31 years Dr. Swanney has developed extensive experience in the corporate aspects of health care provisions both in the public and private sectors. Dr. Swanney left Pfizer Canada to return to British Columbia to set up a private medical practice and was a founding partner in the Family Medicine Research Centre conducting research for both government and industry. Dr. Swanney's experience includes setting up and developing services for a major mining company, developing drug and alcohol treatment programs, a term as a School Trustee and held the position of president of MSA General Hospital a large medical staff organization.
Dr. Swanney holds a post graduate qualifications in Medical Jurisprudence and Toxicology obtaining his medical degree from Glasgow Scotland in 1969 and working as industrial medical director for Rolls Royce (1971) Ltd. prior to joining Placer Development in 1973. Dr. Swanney joined Pfizer Canada in 1979 and gained invaluable experience in the pharmaceutical and corporate industry throughout Canada.
Luna Medical Technologies Ltd. is also pleased to announce the appointment of Ms. Elizabeth Findlay as a Director of Luna Medical Technologies Inc. Ms. Findlay has extensive management expertise in acute care and surgical services. Ms. Findlay was a founding partner of the Women's Health Centers recently acquired by Luna Medical Technologies Inc.
Ms. Findlay holds a Master Degree in Education and a Bachelor of Nursing Science. She is extremely familiar with the medical systems and the opportunities in both Canada and the United States. Ms Findlay will add both depth and expertise in the development of the Women's Health Centers together with a high level of practical experience in the micro management of the health care industry.
Mr. Stuart McNeill, the former President of Luna Medical Technologies Inc., will remain on the Board of Directors of the Company and is pleased to welcome both Dr. Swanney and Ms. Findlay to the Board of Directors.
About Luna Medical Technologies Inc.
Luna Medical Technologies is positioning itself as medical holding company with a mandate to identify and acquire companies in the medical sector that will generate significant revenues in the areas of biotechnology, private medical facilities and medical products. These target companies will provide important contributions and cutting edge solutions to the health care industry and the expanding aging population.
On behalf of the Company --------------------------------------- Dr. J. Swanney President and Director
For further information please visit the companies website at www.lunamedical.com:
This press release includes certain statements that may be deemed to be "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts, included in this press release that address activities, events or developments that the company expects, believes or anticipates will or may occur in the future are forward-looking statements. Such forward-looking statements are subject to certain risks, uncertainties and other factors, which could cause actual results to differ materially from those currently anticipated, including the risks and uncertainties set forth from time to time in the company's public reports and filings and other public statements. Readers are cautioned to consider these risks and uncertainties and not place undue reliance on these forward-looking statements. By making these forward-looking statements, Luna Medical Technologies Inc. undertakes no obligation to update these statements for revisions or changes after the date of this release.
Shares Issued: 8,100,000 October 16th close $0.48